Sixty million people in sub-Saharan Africa live at risk of African sleeping sickness, a disease caused by parasites transmitted through the tsetse fly. In the late stage of the disease, when the parasite crosses the blood-brain barrier, the results are oftentimes fatal.
BYU chemistry professor Ken Christensen, students and collaborators at Clemson University have developed an innovative technique using biosensors to monitor the glucose level of Trypanasoma brucei parasites, which could in turn help develop treatments for the sleeping sickness.
“The unique thing about the T. brucei parasite is that it relies on host glucose for survival,” said Christensen, whose study was recently published in top-ranked journal PLOS Neglected Tropical Diseases. “We know that if you could deprive the parasites in the blood stream of glucose, the parasite will die.”
For the study, Christensen tested glucose levels to monitor the metabolism of the parasites using a genetically-encoded glucose biosensor. The biosensor combines three proteins: a cyan florescent protein, a glucose-binding protein, and a yellow florescent protein.
When the glucose-binding protein interacts with glucose in the parasite, the two fluorescent proteins move closer together. Christensen then uses the spectroscopic changes to monitor the fluorescence-intensity ratio between the yellow and cyan proteins. When the proteins are far apart, the blue light from the cyan fluorescent protein remains. But as the proteins move closer together, the blue light goes down and the yellow light from the yellow fluorescent protein increases.
This ratio is proportional to the glucose level in the parasite.
The results obtained from the biosensor provide new insights into the process through which parasites acquire and transport glucose for survival and provide a means to identify molecules that disrupt glucose levels in the parasite.
“In the long run, we hope that some of the glucose-disrupting molecules we are now identifying can be developed into therapeutics to treat African sleeping sickness,” Christensen said.
Learn more: Stopping a tiny — and deadly — fly in its tracks
The Latest on: Sleeping sickness
via Google News
The Latest on: Sleeping sickness
- WHO steps up measures to tackle sleeping sickness in South Sudan on September 14, 2018 at 7:43 am
JUBA, Sept. 14 (Xinhua)--The World Health Organization (WHO) said Friday it has stepped up efforts by training health workers to accelerate the elimination of human African trypanosomiasis (HAT) or sl... […]
- Can AI Help Eliminate Sleeping Sickness? on September 6, 2018 at 7:37 am
EdgeVerve’s Business Applications built on AI platform Infosys Nia™ enables your enterprise to manage specific business areas and make the move from a deterministic to cognitive approach. […]
- Understanding, preventing sleeping sickness on September 5, 2018 at 4:29 am
Since we have seen several cases of Eastern Equine Encephalomyelitis (EEE) in the area this summer, I thought it may be helpful to spend a few minutes reviewing the disease, how it affects horses, and ... […]
- WHO outlines criteria to assess elimination of sleeping sickness on July 17, 2018 at 5:00 pm
18 July 2018 | Geneva – The latest data released by the World Health Organization (WHO) confirm a sustained decrease in the number of new cases of human African trypanosomiasis (HAT, also known as sle... […]
- Sleeping sickness parasites camouflage themselves with sugar on July 10, 2018 at 3:29 am
It has long been known that the pathogens causing sleeping sickness evade the immune system by exchanging their surface proteins. But now scientists at the German Cancer Research Center (DKFZ) have fo... […]
- The world gears-up to eliminate sleeping sickness by 2020 on April 17, 2018 at 5:00 pm
18 April 2018 | Geneva −− An important meeting of national programme coordinators and stakeholders, which begins today at the headquarters of the World Health Organization (WHO), aims to further stren... […]
- Sleeping Sickness Testing Market Prophesied to Grow at a Faster Pace by 2025 on April 4, 2018 at 12:28 am
Albany, NY -- (SBWIRE) -- 04/04/2018 -- Sleeping Sickness is the most common life-threatening infection encountered in patient populations affected in rural areas particularly in African countries. Th... […]
- Sanofi, DNDi seek EMA review for fexinidazole to treat sleeping sickness on January 31, 2018 at 7:55 pm
Sanofi has asked the European Medicines Agency (EMA) to review fexinidazole for the treatment of sleeping sickness. Fexinidazole is being developed in collaboration with the Drugs for Neglected Diseas... […]
- Sanofi: Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment on January 30, 2018 at 11:06 pm
Fexinidazole would be first all-oral treatment* under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa Sanofi submission is the culmination of 10 ... […]
via Bing News